Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAtlantic Lithium Regulatory News (ALL)

Share Price Information for Atlantic Lithium (ALL)

Share Price is delayed by 15 minutes
Get Live Data
16.45    -0.20 (-1.20%)
Bid:
16.45
Ask:
16.70
Spread: 0.25 (1.52%)
Market Cap: £131.85m
ALL Live PriceLast checked at - London Stock Exchange

Intraday Atlantic Lithium Share Chart

Full Year Trading Update

26 Jun 2012 07:00

RNS Number : 1056G
Allocate Software PLC
26 June 2012
Β 

ο»Ώ

ALLOCATE SOFTWARE PLC

("Allocate" or "the Company")

Β 

Β 

Full Year Trading Update

Β 

Allocate Software (AIM: ALL), the leading provider of workforce and compliance optimisation solutions, announces an update on trading for its financial year ended 31 May 2012. The Company's final results will be announced in the week commencing 30 July 2012.

Β 

Highlights

Β 

Β§ Strong financial performance in the year with results expected to be in line with market expectations.

Β 

Β§ Healthcare had another successful year securing new customers across the NHS, in the UK private healthcare sector and overseas.

Β 

Β§ Completed two acquisitions in the financial year: Zircadian in the UK and RosterOn in Australia. Both performed in line with expectations and the cross-sell of different products into the customer base is beginning to yield encouraging results.

Β 

Β§ Defence had a record year, with major contract wins worldwide including the multi million pound agreement with the Australian Defence Forces.

Β 

Healthcare

Β 

Because of the drive in the NHS for efficiency and cost savings, market appetite for the Allocate application suite with its proven ROI remained strong, with new customers, new products, licence renewals and extensions. HealthRoster, our e-rostering product, retained its strong competitive position and was selected in the majority of all competitive tenders in the UK during the fiscal year.

Β 

The release of v10, the fully web-based version of HealthRoster with multi-language capability, positions this product well for further internationalisation. Our Swedish business, Time Care, has again performed well and met expectations as it has now done every year since acquisition. HealthRoster will be available in Swedish as the first internationalisation of HealthRoster in the coming months.

Β 

Leveraging acquisitions - the integration of HealthRoster and the Zircadian products with the rest of the Allocate suite of products provides customers with an end to end solution from planning to scheduling of the medical workforce. In addition, the integration of HealthRoster and the RosterOn product has created a bespoke leading employment awards interpretation engine for the Australian market. The broadening of our product range is creating significant cross-sell opportunities, in line with our strategy.

Β 

Defence

Β 

The Defence business achieved substantial growth and continued diversifying into other geographic regions, generating significant business from overseas. Highlights include:

Β 

Β§ Securing a multi-million pound licence contract with the Australian Defence Department extending the use of Defence Suite across the Army, Navy and civilians under military control.

Β§ Substantial additional Consultancy Services contract extension wins with the Royal Australian Navy, as part of their New Generation Navy programme.

Β§ Two new Consultancy Services contract wins in NATO within their Force Operations Group, and Special Forces HQ.

Β§ Extension of the UK Army Support contract to 2014

Β 

Maritime

Β 

Β§ Secured a new licence agreement with McDermott Inc, a major US offshore engineering company, the third in this sector

Β§ Completed a major Maritime Suite implementation to support SubSea7's global Offshore Oil Services operations

Β 

Β 

Ian Bowles, Chief Executive Officer of Allocate commented: "Despite the global economic environment and the macro economics of UK government spending we have executed well in our industry sectors and I am delighted with the performance of Allocate this year, particularly in the second half.

Β 

"2012 was our sixth consecutive year of record revenue. This consistency of execution, I believe, demonstrates a balance across our business, both in terms of vertical markets and geographical focus, which speaks well to our plans for significant growth over the next three to five years. I am very pleased with this year's performance and look forward to Allocate's continued success in the next financial year".

Β 

Β 

Enquiries:

Allocate Software plc

Ian Bowles - Chief Executive Officer

Chris Gale - Chief Financial Officer

Martin Jeffries - Marketing Director

Β 

Tel: +44 (0) 20 7355 5555

Numis Securities

Nominated adviser - Michael Meade / Simon Willis/ Richard Thomas

Corporate Broking - James Black

Β 

Tel: +44 (0) 20 7260 1000

Gable Communications

Justine James / John Bick

Β 

Tel: +44 (0) 20 7193 7463

M: +44 (0) 7525 324431

Β 

About Allocate Software plc

Allocate Software plc is the leading workforce optimisation software applications provider for world-wide organisations with large, multi-skilled workforces. With a blue chip client base spanning the public and private sector, its key vertical markets include: Healthcare and Defence.

Β 

At the core of the business is Allocate's workforce optimisation software, which organisations use to deploy the right people with the right skills, to the right place at the right time. Headquartered in London, Allocate provides services and support to its increasing international customer base through regional offices in the UK, Sweden, USA, Australia and Malaysia.

Β 

Allocate is quoted on the London Stock Exchange (AIM: ALL). For further information please visit www.allocatesoftware.com.

Β 

Β 

This information is provided by RNS
The company news service from the London Stock Exchange
Β 
END
Β 
Β 
TSTUVRNRUOANUAR
Date   Source Headline
11th May 20267:00 amRNSElevra to Transfer Ewoyaa Rights and Obligations
7th May 20267:00 amRNSBinding Scheme Implementation Deed with Huayou
30th Apr 20267:00 amRNSQuarterly Activities and Cash Flow Report
20th Mar 20263:00 pmRNSTR-1 Notification of Major Holdings
20th Mar 20267:00 amRNSParliamentary Ratification of Ewoyaa Mining Lease
17th Mar 20261:03 pmRNSCorporate Funding Update - Amendment
17th Mar 20267:00 amRNSCorporate Funding Update
17th Mar 20267:00 amRNSCorporate Funding Update
13th Mar 20267:09 amRNSHalf-year Financial Report
13th Mar 20267:09 amRNSHalf-year Financial Report
23rd Feb 20267:00 amRNSCorporate Update
19th Feb 20268:27 amRNSASX Trading Halt
29th Jan 20267:00 amRNSQuarterly Activities and Cash Flow Report
22nd Dec 20257:00 amRNSRatification Process - Ewoyaa Mining Lease
22nd Dec 20257:00 amRNSRatification Process - Ewoyaa Mining Lease
11th Dec 20257:05 amRNSDirector/PDMR Dealings
11th Dec 20257:00 amRNSUpdate re the Ewoyaa Mining Lease
3rd Dec 20257:00 amRNSTR-1 Notification of Major Holdings
27th Nov 20259:25 amRNSResult of Annual General Meeting
27th Nov 20257:05 amRNSAGM Statement
27th Nov 20257:00 amRNSWithdrawal of AGM Resolution
26th Nov 20257:00 amRNSLong State Funding Update
12th Nov 20257:00 amRNSEwoyaa Lithium Project - Mining Lease Update
6th Nov 202510:07 amRNSResult of Extraordinary General Meeting
31st Oct 20257:00 amRNSQuarterly Activities and Cash Flow Report
28th Oct 20257:00 amRNSNotice of Annual General Meeting
20th Oct 20257:00 amRNSPronounced Lithium-in-soil Anomalies
7th Oct 20257:28 amRNSNotice of Extraordinary General Meeting
11th Sep 20257:00 amRNS2025 Annual Financial Report
9th Sep 20257:00 amRNSTR-1 Notification of Major Holdings
3rd Sep 20257:00 amRNSCorporate Funding Update
31st Jul 20257:00 amRNSQuarterly Activities and Cash Flow Report
18th Jul 20257:00 amRNSEwoyaa Lithium Project - Mining Lease Update
11th Jun 20257:00 amRNSLeadership Streamlining and Cost Reductions
22nd May 20257:00 amRNSSpodumene Pegmatite Discovered in Côte d’Ivoire
19th May 20257:00 amRNSLapse of PDMR Options
30th Apr 20257:00 amRNSQuarterly Activities and Cash Flow Report
24th Apr 202511:56 amRNSResponse to Media Reporting
4th Apr 20257:00 amRNSLapse of PDMR Options
14th Mar 20257:00 amRNSHalf-year Financial Report
4th Feb 20254:06 pmRNSResponse to Press Speculation
30th Jan 20257:15 amRNSQuarterly Activities and Cash Flow Report
30th Jan 20257:00 amRNSUpdated Ewoyaa Feldspar Resource Estimate
24th Jan 20257:00 amRNSResignation of Non-Executive Director
23rd Dec 20247:00 amRNSGrant of Performance Rights
16th Dec 20247:00 amRNSTR-1 Notification of Major Holdings
10th Dec 20247:00 amRNSIssue of Equity
29th Nov 20247:51 amRNSResult of AGM
29th Nov 20247:00 amRNSAGM Statement
26th Nov 20247:00 amRNSStatement re Proposed Merger of PLL and SYA

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.